COMPARISON OF FOURTH WAVE VARIANT OF SARS-COV-2 AND ANCESTRAL WAVES, AN EXPERIENCE FROM A TERTIARY CARE HOSPITAL, KARACHI
DOI:
https://doi.org/10.55629/pakjpathol.v33i4.735Abstract
Objective: The study aims to identify the key differences between ancestral strains and the fourth wave variant of SARS-CoV-2 by comparing the epidemiological and clinical profile of patients admitted since the commencement of CoVID-19 disease.
Material and Methods: The data of all those patients who were SARS-CoV-2 positive from March 2020 to February 2022 was collected. Records of 99 patients admitted during the fourth were compared to admitted patients during three previous waves over a period of the past 23 months.
Results: From Jan till 2nd February 2022, 30.6% PCR turned out to be positive which was remarkably raised from our previous records where the positivity record was 9.11%. After October 2021 there was a remarkable reduction in SARS- CoV-2 infection, afterwards, we appreciated a sudden surge in positive cases during the first week of January 2022 (137/557 (24%)). This trend then led to a rise and fall pattern to 290/720(40%), 180/530 (33%) and 68/398 (17%) during the second, third and fourth week of January respectively. The majority of symptomatic patients developed mild disease 335/454(78%) and only 99/454(22%) developed moderate to a severe disease requiring hospitalization which was lower than the previous waves 410/1457(28%). The total mortality rate during the last three waves was 9% which was much higher than the recent strain during which mortality was only 1%.
Conclusion: Major epidemiological and clinical differences were observed between ancestral strains and fourth-wave variants of SARS-CoV-2 with decreased severity, fewer deaths, and a shorter hospital stay.
Keywords: SARS -CoV-2, Omicron variants, Outbreak, Vaccination
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Abeera Ahmed, Muhammad Imran, Fatima Sana, Hafiz Waheed Khan, Syed Rehan Asghar Naqvi, Aisha Siddiqi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.